|1.||Sessler, Jonathan L: 3 articles (11/2013 - 05/2004)|
|2.||Arambula, Jonathan F: 2 articles (11/2013 - 03/2011)|
|3.||Magda, Darren: 2 articles (11/2013 - 04/2004)|
|4.||Siddik, Zahid H: 2 articles (11/2013 - 03/2011)|
|5.||Rosenthal, D I: 2 articles (12/2000 - 01/2000)|
|6.||Preihs, Christian: 1 article (11/2013)|
|7.||Cheon, Jinwoo: 1 article (11/2013)|
|8.||Yoo, Dongwon: 1 article (11/2013)|
|9.||Jeong, Heeyeong: 1 article (11/2013)|
|10.||Li, L: 1 article (07/2011)|
|1.||Colonic Neoplasms (Colon Cancer)
06/01/1996 - "The texaphyrin macrocycle as illustrated by magnetic resonance imaging and 14C-radiolabeled texaphyrin studies was shown to be tumor selective; a tumor-to-muscle ratio of 10.55 was seen after 5 h. "
04/01/2004 - "The central metal composition of texaphyrin compounds is an important determinant of the effect of the texaphyrins on tumor oxygenation."
05/01/1996 - "All tumors were enhanced after injection of Gd-texaphyrin. "
05/01/2004 - "Biodistribution assessment of a lutetium(III) texaphyrin analogue in tumor-bearing mice using NIR Fourier-transform Raman spectroscopy."
12/01/2000 - "Gadolinium (III) texaphyrin (Gd-Tex) (NSC 695238) is a potential radiation sensitizer that selectively localizes in tumors and is detectable by magnetic resonance imaging (MRI). "
|3.||Neoplasm Metastasis (Metastasis)
|4.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/04/2013 - "In particular, the preparation of bismuth and lead texaphyrin complexes as potential α-core emitters for radiotherapy is detailed, as are gadolinium texaphyrin functionalized magnetic nanoparticles with features that make them of interest as dual-mode magnetic resonance imaging contrast agents and as constructs with anticancer activity mediated through ROS-induced sensitization and concurrent hyperthermia. "
|1.||Heterologous Transplantation (Xenotransplantation)